A 76-Year-Old Woman With High Risk Mantle Cell Lymphoma

Kami Maddocks, MD, reviews the case of a 76-year-old woman with stage 4 mantle cell lymphoma and evaluates the role of BTK inhibitors in the treatment of relapsed/refractory disease.

EP. 1: 76-Year-Old-Woman With Stage IV Mantle Cell Lymphoma

June 18th 2020

EP. 2: Assessing Risk Stratification in Mantle Cell Lymphoma

June 18th 2020

EP. 3: First-Line Treatment for Mantle Cell Lymphoma

June 18th 2020

EP. 4: NCCN Guidelines for Relapsed/Refractory MCL

June 18th 2020

EP. 5: Safety and Efficacy of BTK Inhibitors in R/R MCL

June 18th 2020

EP. 6: Role of BTK Inhibition in Mantle Cell Lymphoma

June 18th 2020

EP. 7: Unmet Needs and Future of R/R Mantle Cell Lymphoma

June 18th 2020